Background: Responses to proadrenomedullin NH2-terminal 20 peptide (PAMP), a novel hypotensive peptide formed from preproadrenomedullin, and the effects of inhibition of adrenergic vasomotor tone with the α-receptor antagonist, phentolamine, on responses to PAMP were investigated in the systemic and hindquarters vascular bed of the rat.
Methods and Results: Intravenous injections of PAMP decreased systemic arterial pressure and in the hindquarters vascular bed of the rat under conditions of controlled hindquarters blood flow, intra-arterial injections of PAMP decreased perfusion pressure in a dose-related manner. Following administration of the alpha receptor blocking agent, phentolamine, sys temic depressor and hindquarters vasodilator responses to PAMP were not significantly decreased, whereas phentolamine significantly decreased systemic and hindquarters pressor responses to norepinephrine. Phentolamine had no significant effect on vasodilator responses to bradykinin, albuterol, or to nitroglycerin.
Conelusions: The present data show that PAMP has significant systemic vasodepressor and vasodilator activity in the hindquarters vascular bed of the rat and suggest that vasodepressor and hindquarters vasodilator responses to PAMP are not dependent upon the presence of adrenergic vasomotor tone.
Kitamura K., Sakata J., Kangawa K., Kojima M, Matsuo H, Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun194:720, 1994
2.
Sakata J., Shimokubo T., Kitamura K., et al. Molecular cloning and biological activities of rad adrenomedullin, a hypotensive peptide. Biochem Biophys Res Commun195:921, 1993
3.
Washimine H., Kitamura K., Ichiki Y., et al. Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine. Biochem Biophys Res Commun202:1081, 1994
4.
Kitamura K., Kangawa K., Ishiyama Y., et al. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP). FEBS Lett351:35, 1994
5.
Katoh F., Kitamura K., Niina H., et al. Proadrenomedullin N-terminal 20 peptide (PAMP), an endogenous anticholinergic peptide: its exocytotic secretion and inhibition of catecholamine secretion in adrenal medulla. J Neurochem64:459, 1994
6.
Shimosawa T. , Ito Y., Ando K., Kitamura K., Kangawa K., Fujita T.Proadrenomedullin NH(2)-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings. J Clin Invest96:1672, 1995
7.
Shimosawa T. , Fujita T.Hypotensive effect of a newly identified peptide, proadrenomedullin N-terminal 20 peptide. Hypertension28:325, 1996
